Literature DB >> 32001993

Total hip arthroplasty for Protrusio Acetabuli in a young adult Osteogenesis Imperfecta features and Marfanoid features: A case report.

Jihad M Ajlouni1, Ula N Isleem2, Ahmad E Al Elaumi1.   

Abstract

Osteogenesis Imperfecta is an inherited disease characterized by easily-broken bones, which manifests as multiple fractures with minimal trauma, joint laxity, sclerosis, blue sclera, and several other manifestations. Protrusio acetabuli is defined as the displacement of the femoral head so that it lies medial to the ischioilial line. In a skeletally mature patient with both Marfan syndrome and PA, an eventual hip arthroplasty is the only method available for correction of the deformity. However, in patients with Osteogenesis Imperfecta and PA, THA remains a controversial treatment. A 14-year-old male patient diagnosed with Osteogenesis Imperfecta Type 1A presented to the orthopedic surgery clinic complaining of groin pain of 1-year duration radiating to the thigh and knee. The patient was found to have radiologic signs of protrusion acetabuli. The patient was started with bisphosphonate and after medical failure, underwent a Total Hip Arthroplasty (THA). In post-operative follow-ups, the patient had relief of pain and was able to walk more comfortably and without a lump. The previously operated hip was examined and showed no signs of infection, dislocation, or fracture. Radiographic studies show no evidence of prosthesis failure or loosening with valgus position of the femoral stem and neutral acetabular angle. Ten years after the primary arthroplasty, the previously operated hip had maintained its stability and had no related complications. Despite the controversy surrounding the treatment of younger patients with hip failure, using total hip arthroplasty, this patient exhibited excellent results, with vast improvement in their symptoms and stability.
© 2019 Delhi Orthopedic Association. All rights reserved.

Entities:  

Year:  2019        PMID: 32001993      PMCID: PMC6985030          DOI: 10.1016/j.jcot.2019.05.016

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  8 in total

Review 1.  Protrusio acetabuli.

Authors:  Colin C R Dunlop; Charles Wynn Jones; Nicola Maffulli
Journal:  Bull Hosp Jt Dis       Date:  2005

Review 2.  Marfan syndrome: an update of genetics, medical and surgical management.

Authors:  Yskert von Kodolitsch; Peter N Robinson
Journal:  Heart       Date:  2007-06       Impact factor: 5.994

Review 3.  Treatment of osteogenesis imperfecta in adults.

Authors:  Katarina Lindahl; Bente Langdahl; Östen Ljunggren; Andreas Kindmark
Journal:  Eur J Endocrinol       Date:  2014-04-23       Impact factor: 6.664

Review 4.  Challenges of Fracture Management for Adults With Osteogenesis Imperfecta.

Authors:  Joseph A Gil; Steven F DeFroda; Kunal Sindhu; Aristides I Cruz; Alan H Daniels
Journal:  Orthopedics       Date:  2016-10-13       Impact factor: 1.390

5.  The revised Ghent nosology for the Marfan syndrome.

Authors:  Bart L Loeys; Harry C Dietz; Alan C Braverman; Bert L Callewaert; Julie De Backer; Richard B Devereux; Yvonne Hilhorst-Hofstee; Guillaume Jondeau; Laurence Faivre; Dianna M Milewicz; Reed E Pyeritz; Paul D Sponseller; Paul Wordsworth; Anne M De Paepe
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

Review 6.  Marfan's syndrome and the heart.

Authors:  Alan Graham Stuart; Andrew Williams
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

Review 7.  Recent developments in osteogenesis imperfecta.

Authors:  Joseph L Shaker; Carolyne Albert; Jessica Fritz; Gerald Harris
Journal:  F1000Res       Date:  2015-09-07

Review 8.  Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.

Authors:  F S Van Dijk; D O Sillence
Journal:  Am J Med Genet A       Date:  2014-04-08       Impact factor: 2.802

  8 in total
  1 in total

Review 1.  Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.

Authors:  Anthony Tucker-Bartley; Jordan Lemme; Andrea Gomez-Morad; Nehal Shah; Miranda Veliu; Frank Birklein; Claudia Storz; Seward Rutkove; David Kronn; Alison M Boyce; Eduard Kraft; Jaymin Upadhyay
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.